BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 21666562)

  • 1. K-ras role in lung cancer therapy.
    Zhang Z; Wang Z
    Minerva Chir; 2011 Jun; 66(3):251-68. PubMed ID: 21666562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiling of transcripts and proteins modulated by K-ras oncogene in the lung tissues of K-ras transgenic mice by omics approaches.
    Lee S; Kang J; Cho M; Seo E; Choi H; Kim E; Kim J; Kim H; Kang GY; Kim KP; Park YH; Yu DY; Yum YN; Park SN; Yoon DY
    Int J Oncol; 2009 Jan; 34(1):161-72. PubMed ID: 19082487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A simple look at the molecular biology of lung cancer: K-Ras].
    Lena H; Corre R; Denis M
    Rev Mal Respir; 2010 Jun; 27(6):639-43. PubMed ID: 20610078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ras gene family in human non-small-cell lung cancer.
    Slebos RJ; Rodenhuis S
    J Natl Cancer Inst Monogr; 1992; (13):23-9. PubMed ID: 1327034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ras signal transduction in carcinogenesis and progression of bladder cancer: molecular target for treatment?
    Shinohara N; Koyanagi T
    Urol Res; 2002 Oct; 30(5):273-81. PubMed ID: 12389114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mouse models of K-ras-initiated oncogenesis].
    Barrière C; Marjou FE; Louvard D; Robine S
    Bull Cancer; 2009 Dec; 96 Suppl():S5-14. PubMed ID: 20034865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular staging of non-small cell lung cancer according to K-ras genotypes.
    Rosell R; Monzó M; Pifarré A; Ariza A; Sánchez JJ; Moreno I; Maurel J; López MP; Abad A; de Anta JM
    Clin Cancer Res; 1996 Jun; 2(6):1083-6. PubMed ID: 9816271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. K-ras oncogene activation in atypical alveolar hyperplasias of the human lung.
    Westra WH; Baas IO; Hruban RH; Askin FB; Wilson K; Offerhaus GJ; Slebos RJ
    Cancer Res; 1996 May; 56(9):2224-8. PubMed ID: 8616876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expressions of 8-OH-dG, k-ras, and p53 genes in pleural effusion cells and their clinical significances].
    Fu XY; Bin XN; Tan M
    Ai Zheng; 2005 Mar; 24(3):345-8. PubMed ID: 15757539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A study on the role of DNA repair gene O6-methylguanine-DNA methyltransferase in the development of human lung cancer].
    Lu JC; Shi LY; Wu ZL; Liao YD; Zhou S; Wang XY; Li YY; Bin XN; Zeng BH; Chen JK
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jan; 24(1):40-4. PubMed ID: 12678962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. K-ras activation in non-small cell lung cancer in the dog.
    Kraegel SA; Gumerlock PH; Dungworth DL; Oreffo VI; Madewell BR
    Cancer Res; 1992 Sep; 52(17):4724-7. PubMed ID: 1324792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of growth inhibition of lung cancer cells by siRNA targeting mutant K-ras gene in vitro and in vivo].
    Zhang ZP; Jiang GC; Yang F; Zhou ZL; Wang J
    Zhonghua Wai Ke Za Zhi; 2007 Sep; 45(18):1267-70. PubMed ID: 18067742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
    Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H
    Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of retrovirus expression of interfering RNA to determine the contribution of activated K-Ras and ras effector expression to human tumor cell growth.
    Baines AT; Lim KH; Shields JM; Lambert JM; Counter CM; Der CJ; Cox AD
    Methods Enzymol; 2006; 407():556-74. PubMed ID: 16757353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations of ras genes distinguish a subset of non-small-cell lung cancer cell lines from small-cell lung cancer cell lines.
    Mitsudomi T; Viallet J; Mulshine JL; Linnoila RI; Minna JD; Gazdar AF
    Oncogene; 1991 Aug; 6(8):1353-62. PubMed ID: 1679529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence of ras mutations in human lung cancer. Minireview.
    Vachtenheim J
    Neoplasma; 1997; 44(3):145-9. PubMed ID: 9372854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF.
    Chou YT; Lin HH; Lien YC; Wang YH; Hong CF; Kao YR; Lin SC; Chang YC; Lin SY; Chen SJ; Chen HC; Yeh SD; Wu CW
    Cancer Res; 2010 Nov; 70(21):8822-31. PubMed ID: 20978205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GSTM1, P53 and K-ras molecular detection in resectable non-small cell lung cancer by denaturing gradient gel electrophoresis-bronchoalveolar lavage fluid analysis.
    Curigliano G; Ferretti G; Mandalà M; De Pas T; Calabrò MG; Solli P; Noberasc C; de Braud F
    Anticancer Res; 2001; 21(5):3461-9. PubMed ID: 11848510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of mutated K-ras gene in surgically resected non-small cell lung cancer patients.
    Rosell R; Li S; Skacel Z; Mate JL; Maestre J; Canela M; Tolosa E; Armengol P; Barnadas A; Ariza A
    Oncogene; 1993 Sep; 8(9):2407-12. PubMed ID: 8395679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-tumorigenic effect of a K-ras ribozyme against human lung cancer cell line heterotransplants in nude mice.
    Zhang YA; Nemunaitis J; Scanlon KJ; Tong AW
    Gene Ther; 2000 Dec; 7(23):2041-50. PubMed ID: 11175317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.